References
- Chatterjee N, Hartge P, Cerhan J R, Cozen W, Davis S, Ischibe N, et al. Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers. Cancer Epidemiol Biomarkers Prev 2004; 13: 1415–1421
- Chang E T, Smedby K E, Hjalgrim H, Porwit-MacDonald A, Roos G, Glimelius B, Adami H. Family history of hematopoietic malignancy and risk of lymphoma. J Natl Cancer Institute 2005; 97: 1466–1474
- Goldin L R, Landgren O, Mc Master M L, Gridley G, Hemminki K, Li X, et al. Familial aggregation and heterogeneity of non Hodgkin lymphoma in population-based samples. Cancer Epidemiol Biomarkers Prev 2005; 14: 2402–2406
- Ferraris A M, Racchi O, Rapezzi D, Gaetani G F, Boffetta P. Familial Hodgkin's disease: a disease of young adulthood. Ann Hematol 1997; 74: 131–134
- Mack T M, Cozen W, Shibata D K, Weiss L M, Nathwani B N, Hernandez A M, et al. Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. New Eng J Med 1995; 332: 413–418
- Hjalgrim H, Askling J, Rostgaard K, Hamilton-Dutoit S, Frisch M, Zhang J S, et al. Characteristics of Hodgkin's lymphoma after infectious mononucleosis. New Eng J Med 2003; 349: 1324–1332
- Campbell G N, Lloyd J, Wotherspoon A, Coulter C, Bain B J. Nodular lymphocyte predominant Hodgkin lymphoma in siblings. Leuk Lymphoma 2004; 45: 609–611
- Haim N, Cohen Y, Robinson E. Malignant lymphoma in first-degree blood relatives. Cancer 1982; 49: 2197–2200
- Kerzin-Storrar L, Faed M J, MacGillivray J B, Smith P G. Incidence of familial Hodgkin's disease. Br J Cancer 1983; 47: 707–712
- Glaser S L, Lin R J, Stewart S L, Ambinder R F, Jarret R F, Brousset P, et al. Epstein-Barr virus-associated Hodgkins disease: epidemiologic characteristics in international data. Int J Cancer 1999; 70: 375–378
- Weiss L M, Strickler J G, Warnke R, Purtilo D T, Sklar J. Epstein-Barr viral DNA in tissues of Hodgkins disease. Am J Pathol 1987; 129: 86–91
- Kamper P M, Kjeldsen E, Clausen N, Bendix K, Dutoit S H, d'Amore F. Epstein-Barr virus-associated familial Hodgkin lymphoma: pediatric onset in three of five siblings. Br J Hematol 2005; 129: 615–617
- Bauduer F, Vassallo J, Delsol G, Brousset P. Clustering and anticipation for nodular lymphocute predominance Hodgkin lymphoma within a French Basque kindred. Br J Hematol 2005; 130: 6481
- Unal A, Seri I, Deniz K, Ozkan M, Kontas O, Eser B, et al. Familial nodular lymphocyte predominant Hodgkin lymphoma: successful treatment with CHOP plus rituximab. Leuk Lymphoma 2005; 46: 1613–1617
- Boudova L, Torlakovic E, Delabie J, Reimer P, Pfistner B, Wiedenmann S, et al. Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma. Blood 2003; 102: 3753–3758
- Rudiger T, Gascoyne R D, Jaffe E S, de Jong D, Delabie J, De Wolf-Peeters C, et al. Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell/histiocyte-rich B cell lymphoma. Ann Oncol 2002; 13(Suppl 1)44–51
- Chakravarti A, Halloran S L, Bale S J, Tucker M A. Etiological heterogeneity in Hodgkin's disease: HLA linked and unlinked determination of susceptibility independent of histological concordance. Genet Epidemiol 1986; 3: 407–415